The Europe Myomectomy Market would witness market growth of 13.1% CAGR during the forecast period (2020-2026). Myomectomy is different from the hysterectomy. The surgeons take out only the fibroids present in the uterus in a myomectomy, while the entire uterus is removed in a hysterectomy. Therefore, myomectomy preserves the chances of getting pregnant for the women undergoing such treatments. There are four major types of myomectomy. They are hysteroscopic, laparoscopic, abdominal, and robotic. The myomectomy results are found to be better and have proved that women also report about the improvement in fibroid symptoms, such as pelvic pressure, and heavy menstrual bleeding.
Moreover, a rise in the number of patients who prefer non-invasive treatment is anticipated to drive the market growth during the foreseeable period. In recent times, numerous minimal/non-invasive myomectomy techniques have been introduced by the manufacturing companies into the market that is capable of destroying fibroids efficiently and preserve the normal functioning of the uterus for future pregnancy. Currently, non or less invasive treatments like laparoscopic, or robotically-assisted myomectomy procedures that are technologically advanced devices are been favored as a choice of fibroid treatment options among women.
These non-invasive devices create a high-energy wave, which causes heats and terminates small areas of fibroid tissue. These procedures actually offer incisionless surgeries that involve no pain and blood loss and they also don’t require hospitalization. In addition, this type of procedure is also helpful in preserving the cervix, uterus, and ovaries, which are beneficial for childbearing reproductive-age women. Patients also find these techniques are more comfortable, and thus they improve patient compliance. All these factors are expected to drive the market growth.
Based on Type, the market is segmented into Abdominal Myomectomy, Hysteroscopic Myomectomy and Laparoscopic Myomectomy. Based on Product, the market is segmented into Harmonic Scalpel, Laparoscopic Sealer, Laparoscopic Power Morcellators and Other Products. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: Myomectomy Market in Europe is expected to register a CAGR of 13.1% during the forecast period (2020-2026)
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Johnson and Johnson, Hologic, Inc., Karl Storz SE & Co. KG, B. Braun Melsungen AG, ConMed Corporation, Intuitive Surgical, Inc., The Cooper Companies, Inc., and Minerva Surgical, Inc.
Market Segmentation:
By Type
By Product
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
